LDLR and atherosclerosis: Since tsRNA-Glu-CTC ASO treatment led to improved lipid profiles in HCD-fed WT mice, we next investigated whether knockdown of tsRNA-Glu-CTC can affect atherosclerosis development in atherosclerosis-prone Ldl receptor-deficient (Ldlr-/-) mice.